Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jul 21, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹581.8626-0.1% 1 day change | 18.37% p.a. | ₹8,352 Cr |
Expense ratio | 0.89% as on May 31, 2025 |
Exit load | 1.0% Exit load of 1% if redeemed within 1 month.! |
AUM (Fund size) | ₹8,352 Cr |
Lock-in Period | Nil |
Age | 12 yrs 6 m since Jan 01, 2013 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP: ₹100 & Lumpsum: ₹5000 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | 2.0% | 3.63% |
3 Months | 5.66% | 6.89% |
6 Months | 6.25% | 5.47% |
1 Year | 13.53% | 17.31% |
2 Years | 26.74% | 29.28% |
3 Years | 25.32% | 26.32% |
4 Years | 14.56% | 15.93% |
5 Years | 22.94% | 23.32% |
7 Years | 21.57% | 22.4% |
10 Years | 15.17% | 13.71% |
Large Cap 36.55%
Mid Cap 31.26%
Small Cap 30.79%
Other Cap 0%
Healthcare 98.60000000000004%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Repo 1.52%
Margin Money 7.4352E-4%
Others 1.52%
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
Nippon India Pharma Fund | N.A. | 8,352 Cr | 12 yrs 6 m | 0.89% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 5,295 Cr | 7 yrs 1 m | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | 3,671 Cr | 12 yrs 6 m | 0.9% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 8 m | 0.62% |
Tata India Pharma & HealthCare Fund | N.A. | 1,232 Cr | 9 yrs 7 m | 0.63% |
Mirae Asset Healthcare Fund | N.A. | 2,691 Cr | 7 yrs 1 m | 0.5% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
Nippon India Pharma Fund | 2.0% | 6.25% | 13.53% | 25.32% | 22.94% | 15.17% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.09% | 7.52% | 21.23% | 30.15% | 25.59% | 16.02% |
SBI Healthcare Opportunities Fund | 3.05% | 6.19% | 21.0% | 29.45% | 25.4% | 13.03% |
DSP Healthcare Fund | 4.09% | 0.19% | 14.3% | 27.12% | 24.42% | 15.94% |
Tata India Pharma & HealthCare Fund | 3.06% | 3.68% | 13.15% | 25.54% | 23.75% | 13.51% |
Mirae Asset Healthcare Fund | 4.78% | 7.03% | 16.41% | 25.1% | 24.13% | 15.97% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
Nippon India Pharma Fund | 14.76 | 0.9 | 1.27 | 1.87 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.37 | 0.94 | 1.44 | 2.04 |
SBI Healthcare Opportunities Fund | 13.71 | 0.84 | 1.58 | 2.27 |
DSP Healthcare Fund | 14.68 | 0.85 | 1.35 | 2.22 |
Tata India Pharma & HealthCare Fund | 15.95 | 0.99 | 1.2 | 1.83 |
Mirae Asset Healthcare Fund | 16.24 | 1.0 | 1.11 | 1.76 |
Alpha | 1.06 vs. 6.7 Underperformed at beating benchmark |
Sharpe | 1.27 vs. 4.61 Poor risk-adjusted returns |
Beta | 0.9 vs. 0.79 More sensitive to market's ups & downs |
Standard deviation | 14.76 vs. 9.0 More volatile performance |
Fund AUM | 8,352 Cr as on May 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
No. of schemes | 65 view all schemes |
Total AUM | 6,17,875 Cr as on Jun 30, 2025 |
Address | 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai, 400013 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
Nippon India Small Cap Fund | N.A. | 58,029 Cr | 1.75% | 38.29% |
Nippon India Power & Infra Fund | N.A. | 7,417 Cr | -4.53% | 32.91% |
Nippon India Growth Mid Cap Fund | N.A. | 36,836 Cr | 7.49% | 32.78% |
Nippon India Multi Cap Fund | N.A. | 40,261 Cr | 6.11% | 32.54% |
Nippon India Nifty Smallcap 250 Index Fund | N.A. | 2,033 Cr | 2.69% | N.A. |
Nippon India Value Fund | N.A. | 8,664 Cr | 4.58% | 28.15% |
The current Net Asset Value (NAV) of the Nippon India Pharma Fund - Direct Growth plan is approximately ₹581.8626 as of Jul 21, 2025.
The Nippon India Pharma Fund is a 12 yrs 6 m old fund and has delivered average annual returns of 18.37% since inception.
1-Year | 3-Year | 5-Year | 10-Year | Since Inception |
---|---|---|---|---|
13.53% | 25.32% | 22.94% | 15.17% | 18.37% |
The Nippon India Pharma Fund - Direct Growth has an expense ratio of 0.89%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The Nippon India Pharma Fund currently has assets under management (AUM) or fund size valued at approximately 8,352 Cr as on May 31, 2025.
The Nippon India Pharma Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.57% |
Divi's Laboratories Ltd. | 9.49% |
Lupin Ltd. | 5.82% |
Cipla Ltd. | 5.62% |
Dr. Reddy's Laboratories Ltd. | 5.49% |
Apollo Hospitals Enterprise Ltd. | 5.34% |
Medplus Health Services Ltd. | 4.2% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.73% |
Vijaya Diagnostic Centre Ltd. | 3.24% |
Narayana Hrudayalaya Ltd. | 2.94% |
The Nippon India Pharma Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 98.60000000000004% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in Nippon India Pharma Fund is complete.
Redeeming your investments in Nippon India Pharma Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in Nippon India Pharma Fund from anywhere else, you can go to the fund house website and put a request through it.